Australian biotech market today 03.04.09

A very flat day’s trading on the ASX saw biotech and pharma go against the grain at the close of trade today, with a slight drop in indices as opposed to overall gains.

Starpharma (ASX:SPL) has called a trading halt until an announcement on Tuesday.

Atcor (ASX:ACG) is down 1c, which still means a 7 per cent drop in value, while Acrux (ASX:ACR) is up 3c, or 5.6 per cent.

Bionomics (ASX:BNO) is down a touch, as is Biota (ASX:BTA).

Circadian Technologies (ASX:CIR) is up 3c, as is CathRx (ASX:CXD), while Clinuvel (ASX:CUV) is up two.

With the Big Three, Cochlear (ASX:COH) has dropped below $50 while CSL (ASX:CSL) is down $1 on high volumes. ResMed (ASX:RMD) is down a touch, too.

Mesoblast (ASX:MSB) is down on a change in substantial shareholding and Pharmaxis (ASX:PXS) is still riding the wave of recent good interim data, up to $1.88.